Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

Reduced Levels of Amyloid-β-Binding Proteins in Cerebrospinal Fluid from Alzheimer's Disease Patients

(2017) Sara F. Hansson et al.   JOURNAL OF ALZHEIMERS DISEASE

High Education May Offer Protection Against Tauopathy in Patients with Mild Cognitive Impairment

(2017) Sindre Rolstad et al.   JOURNAL OF ALZHEIMERS DISEASE

Reducing false positive diagnoses in mild cognitive impairment: the importance of comprehensive neuropsychological assessment

(2014) S. Z. Klekociuk et al.   EUROPEAN JOURNAL OF NEUROLOGY

The neuropsychological profile of vascular cognitive impairment not demented: A meta-analysis

(2014) Brandon P. Vasquez et al.   Journal of Neuropsychology

Targeting the β secretase BACE1 for Alzheimer's disease therapy

(2014) Riqiang Yan et al.   LANCET NEUROLOGY

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease

(2014) Ann Brinkmalm et al.   Molecular Neurodegeneration

Multimodal Markers of Inflammation in the Subcortical Ischemic Vascular Disease Type of Vascular Cognitive Impairment

(2014) Gary A. Rosenberg et al.   STROKE

Active immunotherapy options for Alzheimer’s disease

(2014) Bengt Winblad et al.   Alzheimers Research & Therapy

The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

(2013) Michael W. Weiner et al.   Alzheimers & Dementia

Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre

(2013) Jon B. Toledo et al.   BRAIN

Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study

(2013) Marinella Damian et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)

(2013) Kathryn A. Ellis et al.   INTERNATIONAL PSYCHOGERIATRICS

CSF biomarkers for Alzheimer’s pathology and the effect size of APOE ɛ4

(2013) U Andreasson et al.   MOLECULAR PSYCHIATRY

Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease

(2013) Anja Soldan et al.   NEUROBIOLOGY OF AGING

Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium

(2012) Maria C. Carrillo et al.   Alzheimers & Dementia

All Cognitive Systems but Speed and Visuospatial Functions Reduce the Effect of CSF Pathology on Other Systems

(2012) Sindre Rolstad et al.   Current Alzheimer Research

Low Cerebrospinal Fluid Sulfatide Predicts Progression of White Matter Lesions – The LADIS Study

(2012) Michael Jonsson et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Monte Carlo feature selection and rule-based models to predict Alzheimer’s disease in mild cognitive impairment

(2012) Marcin Kruczyk et al.   JOURNAL OF NEURAL TRANSMISSION

Characteristic clinical presentation and CSF biomarker pattern in cerebral small vessel disease

(2012) Anders Wallin et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI

(2012) Stephanie Vos et al.   NEUROBIOLOGY OF AGING

Age and diagnostic performance of Alzheimer disease CSF biomarkers

(2012) N. Mattsson et al.   NEUROLOGY

Four-year outcome of mild cognitive impairment: The contribution of executive dysfunction.

(2012) Eleni Aretouli et al.   NEUROPSYCHOLOGY

Cerebrovascular Disease and Mechanisms of Cognitive Impairment

(2012) Raj N. Kalaria   STROKE

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

CSF Biomarker and PIB-PET-Derived Beta-Amyloid Signature Predicts Metabolic, Gray Matter, and Cognitive Changes in Nondemented Subjects

(2011) M. Ewers et al.   CEREBRAL CORTEX

2001–2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease?

(2011)   CEREBROVASCULAR DISEASES

Combination of Hippocampal Volume and Cerebrospinal Fluid Biomarkers Improves Predictive Value in Mild Cognitive Impairment

(2011) C. Eckerström et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Progression from Mild to Pronounced MCI Is Not Associated with Cerebrospinal Fluid Biomarker Deviations

(2011) A. Wallin et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

High White Matter Lesion Load Is Associated with Hippocampal Atrophy in Mild Cognitive Impairment

(2011) C. Eckerström et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Vascular Disease, Alzheimer’s Disease Biomarkers and Cognition in Mild Cognitive Impairment: Additive or Synergetic Effects?

(2011) Arto Nordlund et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

The Fate of the 0.5s: Predictors of 2-Year Outcome in Mild Cognitive Impairment

(2011) Eleni Aretouli et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease

(2011) Hong Jiang et al.   Molecular Neurodegeneration

Predicting MCI outcome with clinically available MRI and CSF biomarkers

(2011) D. Heister et al.   NEUROLOGY

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Cerebrospinal Fluid Microglial Markers in Alzheimer’s Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility

(2011) Niklas Mattsson et al.   NEUROMOLECULAR MEDICINE

Matrix Metalloproteinases Are Associated With Increased Blood–Brain Barrier Opening in Vascular Cognitive Impairment

(2011) Eduardo Candelario-Jalil et al.   STROKE

Intrathecal synthesis of immunoglobulin G in vascular dementia

(2010) A. Wallin et al.   ACTA NEUROLOGICA SCANDINAVICA

Blood brain barrier function in vascular dementia

(2010) A. Wallin et al.   ACTA NEUROLOGICA SCANDINAVICA

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors

(2010) K. Blennow et al.   ACTA NEUROLOGICA SCANDINAVICA

Thyroid Hormones Are Associated with Poorer Cognition in Mild Cognitive Impairment

(2010) Patrick Quinlan et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cognitive Profiles of Incipient Dementia in the Goteborg MCI Study

(2010) Arto Nordlund et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Management of Mixed Dementia

(2010) Dina Zekry et al.   DRUGS & AGING

Memory in individuals with mild cognitive impairment in relation to APOE and CSF Aβ42

(2010) Valgeir Thorvaldsson et al.   INTERNATIONAL PSYCHOGERIATRICS

Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory

(2010) Julien Dumurgier et al.   NEUROBIOLOGY OF DISEASE

A Mouse Model Characterizing Features of Vascular Dementia With Hippocampal Atrophy

(2010) Keiko Nishio et al.   STROKE

Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive Impairment

(2009) Maria Bjerke et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cognitive Reserve in Relation to Abeta42 in Patients Converting from MCI to Dementia – A Follow-Up Report

(2009) S. Rolstad et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Biomarkers in Relation to Cognitive Reserve in Patients with Mild Cognitive Impairment – Proof of Concept

(2009) S. Rolstad et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study

(2009) M. Jonsson et al.   EUROPEAN JOURNAL OF NEUROLOGY

Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies

(2009) Feng Shi et al.   HIPPOCAMPUS

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study

(2009) A. Nordlund et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Increased CSF-BACE 1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment and Alzheimer's disease

(2008) Michael Ewers et al.   BRAIN

Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI

(2008) ARTO NORDLUND et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: The Göteborg MCI study

(2008) C. Eckerström et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Progression of White Matter Hyperintensities and Incidence of New Lacunes Over a 3-Year Period

(2008) Alida A. Gouw et al.   STROKE

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

(2007) Miroslaw Brys et al.   NEUROBIOLOGY OF AGING